News
The most recent news and industry headlines are presented in this section. Our dedicated team closely observes the pharmaceutical industry and keeps you informed of the most recent developments around the Europe.
Sanofi's Wayrilz Approved in the EU as First BTK Inhibitor for Immune Thrombocytopenia
Thursday, December 25, 2025The European Commission has approved Sanofis Wayrilz rilzabrutinib as the first BTK inhibitor for adult patients with immune thrombocytopenia refractory to other treatments based on phase LUNA study results
Sanofi's Wayrilz Approved in the EU as First BTK Inhibitor for Immune Thrombocytopenia
Wednesday, December 24, 2025The European Commission has approved Sanofis Wayrilz rilzabrutinib as the first BTK inhibitor for adult patients with immune thrombocytopenia refractory to other treatments based on phase LUNA study results
U.S. FDA approves JASCAYD® (nerandomilast) tablets for progressive pulmonary fibrosis in adults
Tuesday, December 23, 2025Boehringer Ingelheim has received approval from the US Food and Drug Administration FDA for JASCAYD nerandomilast tablets to treat adults with progressive pulmonary fibrosis PPF The approval provides a new treatment option in the US for this serious...
Alvotech and Advanz Achieve Global First with Golimumab Biosimilar Launch in EU and UK
Tuesday, December 23, 2025Alvotech and Advanz Pharma have launched the worlds first golimumab biosimilar in the EU and UK on December marking a significant milestone in biopharma accessibility
Cartography receives FDA IND approval and Fast Track status for CBI-1214 in colorectal cancer
Friday, December 19, 2025Cartography Biosciences has received approval from the US Food and Drug Administration FDA for its Investigational New Drug IND application for CBI the companys lead programme
European Union Reaches Landmark Agreement on Comprehensive Pharmaceutical Market Reform
Friday, December 19, 2025EU legislators have agreed on the most farreaching overhaul of the European pharmaceutical framework in over two decades reshaping incentives data exclusivity market access and RD obligations for drug makers operating in Europe
Sanofi Gains European Commission Approval for Sarclisa in Combination with VRd for Newly Diagnosed Multiple Myeloma Patients
Thursday, December 18, 2025Sanofi has received European Commission approval for Sarclisa combined with VRd as a firstline treatment for newly diagnosed multiple myeloma patients ineligible for autologous stem cell transplant
Protalix Biotherapeutics and Secarna Pharmaceuticals Form Collaboration and Option Agreement
Thursday, December 18, 2025Protalix BioTherapeutics and Secarna Pharmaceuticals have entered into a collaboration and option agreement to develop new antisense oligonucleotide ASO therapies for rare kidney diseases
INCOG BioPharma Announces $200 Million Investment to Expand Operations and Grow Workforce to Nearly 1,000
Wednesday, December 17, 2025INCOG BioPharma Services has announced a further expansion with an investment of around million in its injectable drug manufacturing plant in Fishers Indiana The investment will significantly
Dren Bio Expands Strategic Collaboration with Sanofi to Develop Next-Generation B-Cell Depletion Therapy
Tuesday, December 16, 2025Dren Bio a privately held clinicalstage biotechnology company has expanded its strategic collaboration with Sanofi to discover and develop a nextgeneration Bcell depletion therapy for the treatment of autoimmune diseases
